Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2).

× No keyword cloud information.

47 in total

Review 1. ATP-binding cassette, subfamily G (ABCG family).

Authors: Hiroyuki Kusuhara; Yuichi Sugiyama
Journal: Pflugers Arch Date: 2006-09-16 Impact factor: 3.657

2. ABCG2 expression, function, and promoter methylation in human multiple myeloma.

Authors: Joel G Turner; Jana L Gump; Chunchun Zhang; James M Cook; Douglas Marchion; Lori Hazlehurst; Pamela Munster; Michael J Schell; William S Dalton; Daniel M Sullivan
Journal: Blood Date: 2006-08-17 Impact factor: 22.113

3. A novel nanoparticle formulation overcomes multiple types of membrane efflux pumps in human breast cancer cells.

Authors: Preethy Prasad; Ji Cheng; Adam Shuhendler; Andrew M Rauth; Xiao Yu Wu
Journal: Drug Deliv Transl Res Date: 2012-04 Impact factor: 4.617

Review 4. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Authors: Karthika Natarajan; Yi Xie; Maria R Baer; Douglas D Ross
Journal: Biochem Pharmacol Date: 2012-01-11 Impact factor: 5.858

5. Shikonin enhances Adriamycin antitumor effects by inhibiting efflux pumps in A549 cells.

Authors: Xuchun Liu; Gengyun Sun
Journal: Oncol Lett Date: 2017-08-02 Impact factor: 2.967

6. Role of the breast cancer resistance protein (ABCG2) in drug transport.

Authors: Qingcheng Mao; Jashvant D Unadkat
Journal: AAPS J Date: 2005-05-11 Impact factor: 4.009

7. Licochalcone A Selectively Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs.

Authors: Chung-Pu Wu; Sabrina Lusvarghi; Sung-Han Hsiao; Te-Chun Liu; Yan-Qing Li; Yang-Hui Huang; Tai-Ho Hung; Suresh V Ambudkar
Journal: J Nat Prod Date: 2020-04-29 Impact factor: 4.050

8. The epidermal growth factor tyrosine kinase inhibitor AG1478 and erlotinib reverse ABCG2-mediated drug resistance.

Authors: Zhi Shi; Smitaben Parmar; Xing-Xiang Peng; Tong Shen; Robert W Robey; Susan E Bates; Li-Wu Fu; Yining Shao; Yang-Min Chen; Feiyang Zang; Zhe-Sheng Chen
Journal: Oncol Rep Date: 2009-02 Impact factor: 3.906

Review 9. Nuclear-receptor-mediated regulation of drug- and bile-acid-transporter proteins in gut and liver.

Authors: Jeff L Staudinger; Sarah Woody; Mengxi Sun; Wenqi Cui
Journal: Drug Metab Rev Date: 2013-02 Impact factor: 4.518

10. Development of sulfasalazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNFalpha.

Authors: J van der Heijden; M C de Jong; B A C Dijkmans; W F Lems; R Oerlemans; I Kathmann; C G Schalkwijk; G L Scheffer; R J Scheper; G Jansen
Journal: Ann Rheum Dis Date: 2004-02 Impact factor: 19.103